These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17190640)

  • 1. Acute myelogenous leukemia in a patient receiving etanercept for psoriasis.
    Bachmeyer C; Thiolière B; Khosrotehrani K; Cattan E
    J Am Acad Dermatol; 2007 Jan; 56(1):169-70. PubMed ID: 17190640
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept therapy and acute myeloid leukemia.
    Bachmeyer C
    Am J Hematol; 2008 Apr; 83(4):345; author reply 345. PubMed ID: 18318433
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of myelodysplastic syndrome evolving to acute myeloid leukemia in a patient receiving etanercept for psoriasis.
    Knudson RM; Tefferi A; Pittelkow MR; Davis MDP
    J Am Acad Dermatol; 2011 Sep; 65(3):673-674. PubMed ID: 21839334
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
    Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.
    Cassano N; Coviello C; Loconsole F; Miracapillo A; Vena GA
    Eur J Dermatol; 2006; 16(3):316-7. PubMed ID: 16709508
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.
    Nosotti L; Francesconi F; Izzi S; Berardesca E; Morrone A; Bonifati C
    Br J Dermatol; 2010 Jun; 162(6):1408-10. PubMed ID: 20184582
    [No Abstract]   [Full Text] [Related]  

  • 8. Ability to develop rhus allergic contact dermatitis in a patient with psoriasis receiving etanercept.
    Myers W; Newman M; Katz B; Gottlieb AB
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S127-8. PubMed ID: 17052536
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful use of infliximab following a failed course of etanercept in a pediatric patient.
    Farnsworth NN; George SJ; Hsu S
    Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907
    [No Abstract]   [Full Text] [Related]  

  • 10. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract]   [Full Text] [Related]  

  • 11. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
    Gandhi RK; Pickup T; Sheth PB
    Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept for the treatment of psoriasis.
    Bissonnette R
    Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis.
    Stewart L; Howat A; Coulson I
    Arch Dermatol; 2010 Oct; 146(10):1193-4. PubMed ID: 20956674
    [No Abstract]   [Full Text] [Related]  

  • 14. Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.
    Antoniou C; Kosmadaki MG; Stratigos AJ; Katsambas AD
    Dermatology; 2008; 216(4):364-5. PubMed ID: 18285688
    [No Abstract]   [Full Text] [Related]  

  • 15. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
    Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma.
    Chong BF; Wong HK
    Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
    Yamauchi PS; Lowe NJ
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
    [No Abstract]   [Full Text] [Related]  

  • 19. [Episode of pustular psoriasis after a tuberculin test in a patient with plaque psoriasis on treatment with etanercept].
    Guinovart RM; Ferrándiz C; Bielsa I; Carrascosa JM
    Actas Dermosifiliogr; 2011 Dec; 102(10):828-30. PubMed ID: 21798486
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept for psoriasis in the pediatric population: experience in nine patients.
    Hawrot AC; Metry DW; Theos AJ; Levy ML
    Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.